Updated
Nine issuers, including Wave Life Sciences, Faeth Therapeutics, Kiniksa Pharmaceuticals, Weatherford International, Watsco, Celestica, HCA Healthcare and S&P Global, filed Form 8-K current reports with the SEC on Tuesday, October 27, 2026. The feed headlines did not include the contents of the filings, so the reasons for them are not reported. Form 8-K filings disclose material events to investors, but the sources describe no specific development at any of the companies.